• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素疗法在骨质疏松症的预防和管理中的应用。

Estrogen therapy in the prevention and management of osteoporosis.

作者信息

Lindsay R

出版信息

Am J Obstet Gynecol. 1987 May;156(5):1347-51. doi: 10.1016/0002-9378(87)90177-3.

DOI:10.1016/0002-9378(87)90177-3
PMID:3578455
Abstract

Many studies have shown that bone loss accelerates after oophorectomy or the menopause. If estrogen replacement therapy is instituted soon after the onset of these changes, much of this bone loss, and subsequent fractures, can be prevented. Most investigations have evaluated the effects of oral estrogens, but other routes of administration may be equally beneficial. The use of estrogens natural to the human also seems preferential. Several theories have been advanced regarding the mechanism of action of estrogen in this population. The most popular concept holds that estrogen stimulates calcitonin production, but other theories also must be considered since this is controversial and far from proven. A local action of estrogen on the skeleton cannot be ruled out. In addition to estrogen, calcium supplementation and exercise may have roles to play in the prevention and management of osteoporosis.

摘要

许多研究表明,卵巢切除术后或绝经后骨质流失会加速。如果在这些变化开始后不久就开始进行雌激素替代疗法,那么这种骨质流失以及随后的骨折大多是可以预防的。大多数研究评估了口服雌激素的效果,但其他给药途径可能同样有益。使用对人体天然的雌激素似乎也更具优势。关于雌激素在该人群中的作用机制,已经提出了几种理论。最流行的观点认为,雌激素会刺激降钙素的产生,但由于这一观点存在争议且远未得到证实,所以其他理论也必须加以考虑。不能排除雌激素对骨骼的局部作用。除了雌激素外,补充钙和运动在骨质疏松症的预防和管理中可能也发挥着作用。

相似文献

1
Estrogen therapy in the prevention and management of osteoporosis.雌激素疗法在骨质疏松症的预防和管理中的应用。
Am J Obstet Gynecol. 1987 May;156(5):1347-51. doi: 10.1016/0002-9378(87)90177-3.
2
Long-term estrogen replacement therapy prevents bone loss and fractures.长期雌激素替代疗法可预防骨质流失和骨折。
Ann Intern Med. 1985 Mar;102(3):319-24. doi: 10.7326/0003-4819-102-3-319.
3
The role of estrogen replacement therapy in the prevention of osteoporosis.
Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1306-10. doi: 10.1016/s0002-9378(89)80018-3.
4
Understanding and preventing osteoporosis.
Hosp Pract (Off Ed). 1989 Apr 15;24(4):189-204, 209-11, 215 passim. doi: 10.1080/21548331.1989.11703704.
5
Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.绝经后女性中的降钙素及钙调节激素:雌激素的作用
Lancet. 1981 Mar 28;1(8222):693-5. doi: 10.1016/s0140-6736(81)91973-5.
6
[Preventive drug therapy of postmenopausal osteoporosis].
Rev Med Interne. 1993;14(9):877-87. doi: 10.1016/s0248-8663(05)81148-8.
7
Estrogen replacement therapy: current recommendations.
Mayo Clin Proc. 1988 May;63(5):453-60. doi: 10.1016/s0025-6196(12)65642-0.
8
[Prevention of osteoporosis. Review of recent literature].
Fortschr Med. 1983 Apr 28;101(16):743-5.
9
Prevention of bone loss and fractures in women.预防女性骨质流失和骨折。
Maturitas. 1984 Nov;6(3):225-42. doi: 10.1016/0378-5122(84)90039-2.
10
Prevention of osteoporosis.骨质疏松症的预防
Clin Orthop Relat Res. 1987 Sep(222):44-59.

引用本文的文献

1
Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.骨质疏松症新疗法抗骨折疗效替代终点指标开发的考量:一种观点
J Bone Miner Res. 2008 Aug;23(8):1155-67. doi: 10.1359/jbmr.080301.
2
Osteoporosis prevention and treatment with sex hormone replacement therapy.性激素替代疗法用于骨质疏松症的预防和治疗。
Clin Rheumatol. 1995 Sep;14 Suppl 3:14-7. doi: 10.1007/BF02210682.
3
The effect of a weighted vest on perceived health status and bone density in older persons.
Qual Life Res. 1993 Apr;2(2):141-52. doi: 10.1007/BF00435733.
4
Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women.依普黄酮给药对去卵巢女性骨量和代谢的影响。
J Endocrinol Invest. 1993 May;16(5):333-7. doi: 10.1007/BF03348848.
5
The effect of previous oral contraceptive use on bone mineral density in perimenopausal women.既往口服避孕药的使用对围绝经期女性骨密度的影响。
Osteoporos Int. 1994 Mar;4(2):93-8. doi: 10.1007/BF01623231.
6
Reducing the threat of hip fracture.降低髋部骨折的风险。
Am J Public Health. 1989 Mar;79(3):269-70. doi: 10.2105/ajph.79.3.269.
7
[Osteoporosis--prevention with estrogens, progestins].
Arch Gynecol Obstet. 1989;245(1-4):959-62. doi: 10.1007/BF02417636.
8
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.卵巢甾体激素治疗可阻止绝经后血液单核细胞白细胞介素1释放的增加。
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2398-402. doi: 10.1073/pnas.86.7.2398.
9
Sports injuries and oral contraceptive use. Is there a relationship?
Sports Med. 1991 Sep;12(3):152-60. doi: 10.2165/00007256-199112030-00002.
10
Can vigorous exercise play a role in osteoporosis prevention? A review.
Osteoporos Int. 1992 Mar;2(2):55-69. doi: 10.1007/BF01623838.